Clinical trial
An Open Label Multicentre Study to Determine the Dose Distribution of…
NCT00473434 · Janssen-Cilag Pty Ltd, Industry · Completed
Key facts
| NCT number | NCT00473434 |
|---|---|
| Title | An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia |
| Official title | An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia |
| Lead sponsor | Janssen-Cilag Pty Ltd, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Paliperidone |
| Enrollment | 64 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | May 15, 2007 |
| Last update posted | Dec 5, 2012 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: